Skip to main content
Type at least 3 characters

22,285 articles

Original Research

Published on 03 May 2024

Genetic variation in UGT1A1 is not associated with altered liver biochemical parameters in healthy volunteers participating in bioequivalence trials

in Pharmacogenetics and Pharmacogenomics

  • Eva González-Iglesias
  • Dolores Ochoa
  • Manuel Román
  • Paula Soria-Chacartegui
  • Samuel Martín-Vilchez
  • Marcos Navares-Gómez
  • Alejandro De Miguel
  • Pablo Zubiaur
  • Andrea Rodríguez-Lopez
  • Francisco Abad-Santos
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1389968
  • 2,062 views
  • 1 citation

Original Research

Published on 02 May 2024

The influence of the way of regression on the results obtained by the receptorial responsiveness method (RRM), a procedure to estimate a change in the concentration of a pharmacological agonist near the receptor

in Experimental Pharmacology and Drug Discovery

  • Ignac Ovari
  • Gabor Viczjan
  • Tamas Erdei
  • Barbara Takacs
  • Vera Tarjanyi
  • Judit Zsuga
  • Miklos Szucs
  • Zoltan Szilvassy
  • Bela Juhasz
  • Rudolf Gesztelyi
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1375955
  • 1,155 views

Original Research

Published on 02 May 2024

Gastric cancer actionable genomic alterations across diverse populations worldwide and pharmacogenomics strategies based on precision oncology

in Pharmacogenetics and Pharmacogenomics

  • Gabriela Echeverría-Garcés
  • María José Ramos-Medina
  • Rodrigo Vargas
  • Alejandro Cabrera-Andrade
  • Adriana Altamirano-Colina
  • María Paula Freire
  • Juliana Montalvo-Guerrero
  • Sebastián Rivera-Orellana
  • Paulina Echeverría-Espinoza
  • Luis A. Quiñones
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1373007
  • 4,966 views
  • 6 citations